Events
To mark the opening of their new HPAPI zone for OEB4/5+ molecules, Skyepharma is hosting their first symposium "Recent Advances in Overcoming Oral Solid Dosage Form Development Current Challenges". This zone is designed to support the development and manufacturing of HPAPI-based therapies, driving innovation in cancer treatment.
MEDELPHARM has contributed to this impactful project with the installation of a STYL'One Evo DryCon® Compaction Simulator.
As part of the symposium, Bruno LECLERCQ from the MEDELPHARM Science Lab will share his insights on "STYL'One Compaction Simulators: a tool for accelerated tablet development and efficient production support".
Attending:
Comments
No comments posted yet.
Add a comment
Articles you may like
Related products
Looking for additional information?
Let us help you